The vast majority of pharmacologic agents cross the placenta and enter the fetal circulation. In the administration of any drug during pregnancy (for either therapeutic or pleasurable reasons) benefits must be weighed against potential risk to the fetus. Since mood-altering drugs have minimal, if any, therapeutic benefit and an extremely high risk of adverse effects on the fetus, their widespread use during pregnancy must be viewed as a great cause for concern in this country.
|Original language||English (US)|
|Number of pages||19|
|State||Published - 1979|
All Science Journal Classification (ASJC) codes
- Pediatrics, Perinatology, and Child Health